CME TO SUE CFTC OVER PERPS
CME HAS A MONOPOLY OVER US FUTURES MARKETS AT A 92% MARKET SHARE
THE RESULT: LESS COMPETITION, HIGHER FEES AND A MARKET THAT NEVER HAD TO INNOVATE
CFTC CALLS IT “LAWFARE FROM AN INCUMBENT AFRAID TO COMPETE.” EVEN THE REGULATOR IS TIRED OF THEM.